Market Cap 55.82M
Revenue (ttm) 1.02M
Net Income (ttm) -18.46M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,809.80%
Debt to Equity Ratio 0.00
Volume 1,196
Avg Vol 24,878
Day's Range N/A - N/A
Shares Out 3.19M
Stochastic %K 85%
Beta 0.81
Analysts Strong Buy
Price Target $35.00

Latest News on VTVT

vTv Therapeutics Announces Investment by CinRx Pharma

Jul 25, 2022, 7:00 AM EDT - 2 years ago

vTv Therapeutics Announces Investment by CinRx Pharma


vTv Therapeutics Announces CEO Transition

Mar 3, 2022, 8:48 PM EST - 3 years ago

vTv Therapeutics Announces CEO Transition


vTv Therapeutics Shares Updated Corporate Presentation

Jan 13, 2022, 8:30 AM EST - 3 years ago

vTv Therapeutics Shares Updated Corporate Presentation